Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors

doi:10.4330/wjc.v6.i7.555

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4697)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

343

WORD

288

HTML

2279

Sum=2910

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

876

Download

911

Sum=1787

Jul 26, 2014 (publication date) through May 17, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Cardiol. Jul 26, 2014; 6(7): 555-561
Published online Jul 26, 2014. doi: 10.4330/wjc.v6.i7.555

Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors

Serhan Kupeli

Serhan Kupeli, Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Faculty of Medicine, Çukurova University, 01330 Adana, Turkey

Author contributions: Kupeli S solely contributed to this paper.

Correspondence to: Serhan Kupeli, MD, MSc, Associate Professor of Pediatrics, Department of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Faculty of Medicine, Çukurova University, Rektörlüğü, 01330 Adana, Turkey. serhankupeli@cu.edu.tr

Telephone: +90-32-23387444 Fax: +90-32-23387444

Received: December 13, 2013
Revised: April 10, 2014
Accepted: May 14, 2014
Published online: July 26, 2014

Core Tip

Core tip: With substantial increase in survival rates from cancer, late adverse effects of cancer therapy have become extremely important. Mediastinal radiotherapy and cardiotoxic chemotherapeutic agents are routinely used to treat Hodgkin lymphoma (HL) but are commonly associated with a variety of cardiovascular complications including coronary artery disease (CAD). For surviving individuals after HL treatment, coronary computed tomography angiography is a non-invasive and useful method in detecting CAD at an early stage. Survivors of HL especially treated with combined chemoradiotherapy at young ages, who carry the risk of CAD development are candidates for coronary computed tomography angiography.